Biological Products, (No Diagnostic Substances) 8 companies · $75.93B combined revenue
SIC 2836 · official SEC filings
| # | Ticker | Company | Mkt Cap* | Revenue | Net Income | Sector |
|---|---|---|---|---|---|---|
| 1 | AMGN | Amgen Inc | $150.10B | $36.75B | $7.71B | Biological Products, (No Diagnostic Substances) |
| 2 | GILD | Gilead Sciences, Inc. | $103.20B | $29.44B | $8.51B | Biological Products, (No Diagnostic Substances) |
| 3 | NBIX | Neurocrine Biosciences Inc | $9.52B | $2.86B | $478.60M | Biological Products, (No Diagnostic Substances) |
| #4 | EXEL | Exelixis, Inc. | $9.40B | $2.32B | $782.57M | Biological Products, (No Diagnostic Substances) |
| #5 | MRNA | Moderna, Inc. | $9.90B | $1.94B | $-2.82B | Biological Products, (No Diagnostic Substances) |
| #6 | HALO | Halozyme Therapeutics, Inc. | $4.50B | $1.40B | $316.89M | Biological Products, (No Diagnostic Substances) |
| #7 | TECH | Bio-Techne Corp | $9.10B | $1.22B | $73.40M | Biological Products, (No Diagnostic Substances) |
| #8 | BIIB | Biogen Inc. | $18.38B | – | – | Biological Products, (No Diagnostic Substances) |